Dr. Eggington advises policy makers on precision medicine, and is a contributing member of numerous committees, including the CDC/FDA/CMS Next Generation Sequencing Best Practices Forum. She oversees CGI's ELEVATEGENETICS initiative, which helps health insurance payers identify the more accurate and clinically efficacious genetic and genomic tests. Dr. Eggington directed programs at Myriad Genetics, Courtagen, and 23andMe prior to co-founding a genetic diagnostics consultancy company in 2016. The need for a disruptive nonprofit organization became clear through this consulting work, and Dr. Eggington co-founded CGI in 2017. She was a 2019 Sego Award winner for Utah women co-founders/CEOs in Innovation in Technology. Dr. Eggington also holds an affiliate faculty position at Brigham Young University.